RVMD logo

Revolution Medicines (RVMD) Accounts payable

annual accounts payable:

$54.43M-$7.36M(-11.91%)
December 31, 2024

Summary

  • As of today (June 22, 2025), RVMD annual accounts payable is $54.43 million, with the most recent change of -$7.36 million (-11.91%) on December 31, 2024.
  • During the last 3 years, RVMD annual accounts payable has risen by +$40.37 million (+287.19%).
  • RVMD annual accounts payable is now -11.91% below its all-time high of $61.79 million, reached on December 31, 2023.

Performance

RVMD Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRVMDbalance sheet metrics

quarterly accounts payable:

$47.51M-$6.92M(-12.71%)
March 31, 2025

Summary

  • As of today (June 22, 2025), RVMD quarterly accounts payable is $47.51 million, with the most recent change of -$6.92 million (-12.71%) on March 31, 2025.
  • Over the past year, RVMD quarterly accounts payable has increased by +$15.13 million (+46.72%).
  • RVMD quarterly accounts payable is now -23.11% below its all-time high of $61.79 million, reached on December 31, 2023.

Performance

RVMD quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRVMDbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

RVMD Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-11.9%+46.7%
3 y3 years+287.2%+235.2%
5 y5 years+377.4%+503.1%

RVMD Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-11.9%+287.2%-23.1%+237.7%
5 y5-year-11.9%+377.4%-23.1%+613.8%
alltimeall time-11.9%+1523.2%-23.1%+807.3%

RVMD Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$47.51M(-12.7%)
Dec 2024
$54.43M(-11.9%)
$54.43M(+122.6%)
Sep 2024
-
$24.46M(-16.6%)
Jun 2024
-
$29.32M(-9.5%)
Mar 2024
-
$32.38M(-47.6%)
Dec 2023
$61.79M(+190.0%)
$61.79M(+108.6%)
Sep 2023
-
$29.63M(-0.5%)
Jun 2023
-
$29.78M(+49.6%)
Mar 2023
-
$19.91M(-6.5%)
Dec 2022
$21.31M
$21.31M(-12.6%)
Sep 2022
-
$24.38M(+73.3%)
Jun 2022
-
$14.07M(-0.8%)
DateAnnualQuarterly
Mar 2022
-
$14.17M(+0.8%)
Dec 2021
$14.06M(+11.5%)
$14.06M(+34.0%)
Sep 2021
-
$10.49M(+0.5%)
Jun 2021
-
$10.44M(+8.1%)
Mar 2021
-
$9.65M(-23.5%)
Dec 2020
$12.61M(+10.6%)
$12.61M(+89.4%)
Sep 2020
-
$6.66M(-34.6%)
Jun 2020
-
$10.17M(+29.1%)
Mar 2020
-
$7.88M(-30.9%)
Dec 2019
$11.40M(+117.7%)
$11.40M(+89.6%)
Sep 2019
-
$6.01M(+14.8%)
Dec 2018
$5.24M(+56.2%)
$5.24M
Dec 2017
$3.35M
-

FAQ

  • What is Revolution Medicines annual accounts payable?
  • What is the all time high annual accounts payable for Revolution Medicines?
  • What is Revolution Medicines annual accounts payable year-on-year change?
  • What is Revolution Medicines quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Revolution Medicines?
  • What is Revolution Medicines quarterly accounts payable year-on-year change?

What is Revolution Medicines annual accounts payable?

The current annual accounts payable of RVMD is $54.43M

What is the all time high annual accounts payable for Revolution Medicines?

Revolution Medicines all-time high annual accounts payable is $61.79M

What is Revolution Medicines annual accounts payable year-on-year change?

Over the past year, RVMD annual accounts payable has changed by -$7.36M (-11.91%)

What is Revolution Medicines quarterly accounts payable?

The current quarterly accounts payable of RVMD is $47.51M

What is the all time high quarterly accounts payable for Revolution Medicines?

Revolution Medicines all-time high quarterly accounts payable is $61.79M

What is Revolution Medicines quarterly accounts payable year-on-year change?

Over the past year, RVMD quarterly accounts payable has changed by +$15.13M (+46.72%)
On this page